- Home
- FOLD vs AVAL Comparison
FOLD vs AVAL Comparison
Compare FOLD & AVAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- AVAL
- Stock Information
- Founded
- FOLD 2002
- AVAL 1994
- Country
- FOLD United States
- AVAL Colombia
- Employees
- FOLD N/A
- AVAL N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- AVAL Commercial Banks
- Sector
- FOLD Health Care
- AVAL Finance
- Exchange
- FOLD Nasdaq
- AVAL Nasdaq
- Market Cap
- FOLD 2.9B
- AVAL 3.4B
- IPO Year
- FOLD 2007
- AVAL N/A
- Fundamental
- Price
- FOLD $6.16
- AVAL $2.96
- Analyst Decision
- FOLD Buy
- AVAL
- Analyst Count
- FOLD 10
- AVAL 0
- Target Price
- FOLD $16.22
- AVAL N/A
- AVG Volume (30 Days)
- FOLD 5.0M
- AVAL 89.3K
- Earning Date
- FOLD 05-01-2025
- AVAL 05-06-2025
- Dividend Yield
- FOLD N/A
- AVAL 3.69%
- EPS Growth
- FOLD N/A
- AVAL 195.30
- EPS
- FOLD N/A
- AVAL 0.01
- Revenue
- FOLD $543,141,000.00
- AVAL $2,951,771,633.00
- Revenue This Year
- FOLD $19.85
- AVAL $46.54
- Revenue Next Year
- FOLD $23.50
- AVAL $8.90
- P/E Ratio
- FOLD N/A
- AVAL $11.16
- Revenue Growth
- FOLD 28.25
- AVAL 14.20
- 52 Week Low
- FOLD $5.81
- AVAL $1.94
- 52 Week High
- FOLD $12.65
- AVAL $3.32
- Technical
- Relative Strength Index (RSI)
- FOLD 41.91
- AVAL 65.01
- Support Level
- FOLD $6.03
- AVAL $2.75
- Resistance Level
- FOLD $6.37
- AVAL $2.86
- Average True Range (ATR)
- FOLD 0.24
- AVAL 0.12
- MACD
- FOLD 0.04
- AVAL 0.01
- Stochastic Oscillator
- FOLD 41.67
- AVAL 93.33
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About AVAL Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)
Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its segments include: Banking Services segment comprises Banking Services, fund management and trust businesses, storage companies and entities that manage low-value payment systems. Merchant Banking segment comprises Financial Sector (trust and brokerage), Gas and Energy Sector (includes natural gas and energy transportation and distribution businesses), Infrastructure Sector (includes road infrastructure projects, construction services, and operation and maintenance), Hotel Sector (includes hospitality services), Agribusiness Sector (includes palm oil, rubber and rice businesses). Pension and Severance Fund Management" segment comprise administrator of pension and severance funds; and Holding segment.